nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP1A1—Methoxsalen—hematologic cancer	0.0446	0.0817	CbGbCtD
Bezafibrate—CYP1A1—Bortezomib—hematologic cancer	0.0425	0.0777	CbGbCtD
Bezafibrate—CYP1A1—Daunorubicin—hematologic cancer	0.0406	0.0743	CbGbCtD
Bezafibrate—CYP1A1—Thalidomide—hematologic cancer	0.037	0.0677	CbGbCtD
Bezafibrate—CYP1A1—Dacarbazine—hematologic cancer	0.0318	0.0582	CbGbCtD
Bezafibrate—SLCO1B1—Irinotecan—hematologic cancer	0.0265	0.0485	CbGbCtD
Bezafibrate—CYP1A1—Dasatinib—hematologic cancer	0.025	0.0457	CbGbCtD
Bezafibrate—CYP2C8—Bortezomib—hematologic cancer	0.0245	0.0448	CbGbCtD
Bezafibrate—CYP2C8—Ifosfamide—hematologic cancer	0.0188	0.0344	CbGbCtD
Bezafibrate—CYP2C8—Nilotinib—hematologic cancer	0.0163	0.0298	CbGbCtD
Bezafibrate—CYP3A4—Bexarotene—hematologic cancer	0.0162	0.0297	CbGbCtD
Bezafibrate—CYP3A4—Lomustine—hematologic cancer	0.0151	0.0276	CbGbCtD
Bezafibrate—CYP3A4—Busulfan—hematologic cancer	0.0151	0.0276	CbGbCtD
Bezafibrate—SLCO1B1—Methotrexate—hematologic cancer	0.014	0.0257	CbGbCtD
Bezafibrate—CYP3A4—Thiotepa—hematologic cancer	0.0134	0.0246	CbGbCtD
Bezafibrate—CYP1A1—Dexamethasone—hematologic cancer	0.0128	0.0234	CbGbCtD
Bezafibrate—CYP3A4—Methoxsalen—hematologic cancer	0.0104	0.0191	CbGbCtD
Bezafibrate—CYP3A4—Bortezomib—hematologic cancer	0.00994	0.0182	CbGbCtD
Bezafibrate—CYP3A4—Daunorubicin—hematologic cancer	0.00951	0.0174	CbGbCtD
Bezafibrate—CYP2C8—Etoposide—hematologic cancer	0.00898	0.0164	CbGbCtD
Bezafibrate—CYP3A4—Cytarabine—hematologic cancer	0.00838	0.0153	CbGbCtD
Bezafibrate—CYP3A4—Teniposide—hematologic cancer	0.00826	0.0151	CbGbCtD
Bezafibrate—CYP3A4—Ifosfamide—hematologic cancer	0.00762	0.0139	CbGbCtD
Bezafibrate—CYP2C8—Dexamethasone—hematologic cancer	0.00738	0.0135	CbGbCtD
Bezafibrate—CYP3A4—Imatinib—hematologic cancer	0.00728	0.0133	CbGbCtD
Bezafibrate—CYP3A4—Ruxolitinib—hematologic cancer	0.00686	0.0125	CbGbCtD
Bezafibrate—CYP3A4—Nilotinib—hematologic cancer	0.00662	0.0121	CbGbCtD
Bezafibrate—CYP3A4—Vinorelbine—hematologic cancer	0.00656	0.012	CbGbCtD
Bezafibrate—CYP3A4—Triamcinolone—hematologic cancer	0.006	0.011	CbGbCtD
Bezafibrate—CYP3A4—Dasatinib—hematologic cancer	0.00585	0.0107	CbGbCtD
Bezafibrate—CYP3A4—Mitoxantrone—hematologic cancer	0.00578	0.0106	CbGbCtD
Bezafibrate—CYP3A4—Betamethasone—hematologic cancer	0.00515	0.00942	CbGbCtD
Bezafibrate—CYP3A4—Prednisolone—hematologic cancer	0.00508	0.00929	CbGbCtD
Bezafibrate—CYP3A4—Prednisone—hematologic cancer	0.0048	0.00878	CbGbCtD
Bezafibrate—CYP3A4—Irinotecan—hematologic cancer	0.00455	0.00832	CbGbCtD
Bezafibrate—CYP3A4—Vinblastine—hematologic cancer	0.00404	0.0074	CbGbCtD
Bezafibrate—CYP3A4—Vincristine—hematologic cancer	0.00398	0.00727	CbGbCtD
Bezafibrate—PPARD—hematopoietic system—hematologic cancer	0.00394	0.0811	CbGeAlD
Bezafibrate—CYP3A4—Etoposide—hematologic cancer	0.00364	0.00666	CbGbCtD
Bezafibrate—PPARA—hematopoietic system—hematologic cancer	0.00336	0.0691	CbGeAlD
Bezafibrate—CYP3A4—Dexamethasone—hematologic cancer	0.00299	0.00548	CbGbCtD
Bezafibrate—CYP3A4—Doxorubicin—hematologic cancer	0.00248	0.00455	CbGbCtD
Bezafibrate—PPARD—lung—hematologic cancer	0.00229	0.0471	CbGeAlD
Bezafibrate—HMGCR—hematopoietic system—hematologic cancer	0.00223	0.046	CbGeAlD
Bezafibrate—PPARA—blood—hematologic cancer	0.00222	0.0458	CbGeAlD
Bezafibrate—PPARD—testis—hematologic cancer	0.00216	0.0445	CbGeAlD
Bezafibrate—SLCO1B1—hematopoietic system—hematologic cancer	0.00214	0.0441	CbGeAlD
Bezafibrate—PPARA—lung—hematologic cancer	0.00195	0.0401	CbGeAlD
Bezafibrate—PPARG—hematopoietic system—hematologic cancer	0.00185	0.038	CbGeAlD
Bezafibrate—PPARA—testis—hematologic cancer	0.00184	0.0379	CbGeAlD
Bezafibrate—HMGCR—gonad—hematologic cancer	0.0017	0.035	CbGeAlD
Bezafibrate—PPARD—lymph node—hematologic cancer	0.00156	0.0322	CbGeAlD
Bezafibrate—HMGCR—blood—hematologic cancer	0.00148	0.0305	CbGeAlD
Bezafibrate—HMGCR—bone marrow—hematologic cancer	0.00143	0.0295	CbGeAlD
Bezafibrate—SLCO1B1—blood—hematologic cancer	0.00142	0.0292	CbGeAlD
Bezafibrate—PPARA—lymph node—hematologic cancer	0.00133	0.0275	CbGeAlD
Bezafibrate—HMGCR—lung—hematologic cancer	0.0013	0.0267	CbGeAlD
Bezafibrate—PPARG—Ponatinib—Nilotinib—hematologic cancer	0.00128	0.285	CbGdCrCtD
Bezafibrate—HMGCR—testis—hematologic cancer	0.00122	0.0252	CbGeAlD
Bezafibrate—PPARG—blood—hematologic cancer	0.00122	0.0252	CbGeAlD
Bezafibrate—CYP2C8—hematopoietic system—hematologic cancer	0.00122	0.0251	CbGeAlD
Bezafibrate—PPARG—bone marrow—hematologic cancer	0.00118	0.0244	CbGeAlD
Bezafibrate—Balsalazide—ALOX5—hematologic cancer	0.00117	0.31	CrCbGaD
Bezafibrate—CYP1A1—hematopoietic system—hematologic cancer	0.00112	0.0231	CbGeAlD
Bezafibrate—PPARG—lung—hematologic cancer	0.00107	0.0221	CbGeAlD
Bezafibrate—PPARG—testis—hematologic cancer	0.00101	0.0208	CbGeAlD
Bezafibrate—PPARG—Ponatinib—Imatinib—hematologic cancer	0.000966	0.216	CbGdCrCtD
Bezafibrate—PPARG—Topotecan—Irinotecan—hematologic cancer	0.000916	0.204	CbGdCrCtD
Bezafibrate—PPARG—Etoposide—Teniposide—hematologic cancer	0.00091	0.203	CbGdCrCtD
Bezafibrate—HMGCR—lymph node—hematologic cancer	0.000887	0.0183	CbGeAlD
Bezafibrate—CYP3A4—hematopoietic system—hematologic cancer	0.000824	0.017	CbGeAlD
Bezafibrate—CYP2C8—blood—hematologic cancer	0.000806	0.0166	CbGeAlD
Bezafibrate—CYP1A1—blood—hematologic cancer	0.000744	0.0153	CbGeAlD
Bezafibrate—PPARG—lymph node—hematologic cancer	0.000733	0.0151	CbGeAlD
Bezafibrate—CYP2C8—testis—hematologic cancer	0.000667	0.0137	CbGeAlD
Bezafibrate—CYP1A1—lung—hematologic cancer	0.000652	0.0134	CbGeAlD
Bezafibrate—CYP3A4—blood—hematologic cancer	0.000546	0.0112	CbGeAlD
Bezafibrate—Indomethacin—ABCC3—hematologic cancer	0.000524	0.139	CrCbGaD
Bezafibrate—Glyburide—ABCC3—hematologic cancer	0.000473	0.125	CrCbGaD
Bezafibrate—Indomethacin—UGT1A1—hematologic cancer	0.000453	0.12	CrCbGaD
Bezafibrate—CYP1A1—lymph node—hematologic cancer	0.000446	0.00919	CbGeAlD
Bezafibrate—PPARG—Teniposide—Etoposide—hematologic cancer	0.000413	0.0921	CbGdCrCtD
Bezafibrate—Aminohippurate—SLC22A1—hematologic cancer	0.000397	0.105	CrCbGaD
Bezafibrate—Glyburide—ABCG2—hematologic cancer	0.00023	0.0609	CrCbGaD
Bezafibrate—Aminohippurate—ABCB1—hematologic cancer	0.000115	0.0306	CrCbGaD
Bezafibrate—Indomethacin—ALB—hematologic cancer	0.000111	0.0294	CrCbGaD
Bezafibrate—Indomethacin—ABCB1—hematologic cancer	0.000106	0.0281	CrCbGaD
Bezafibrate—Glyburide—ALB—hematologic cancer	0.0001	0.0266	CrCbGaD
Bezafibrate—Glyburide—ABCB1—hematologic cancer	9.56e-05	0.0253	CrCbGaD
Bezafibrate—Pain—Cisplatin—hematologic cancer	8.11e-05	0.00034	CcSEcCtD
Bezafibrate—Dermatitis—Bleomycin—hematologic cancer	8.11e-05	0.00034	CcSEcCtD
Bezafibrate—Hypersensitivity—Ifosfamide—hematologic cancer	8.11e-05	0.00034	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	8.09e-05	0.000339	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	8.09e-05	0.000339	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—hematologic cancer	8.09e-05	0.000339	CcSEcCtD
Bezafibrate—Diarrhoea—Thalidomide—hematologic cancer	8e-05	0.000335	CcSEcCtD
Bezafibrate—Dizziness—Thiotepa—hematologic cancer	8e-05	0.000335	CcSEcCtD
Bezafibrate—Rash—Vinorelbine—hematologic cancer	7.99e-05	0.000335	CcSEcCtD
Bezafibrate—Dermatitis—Vinorelbine—hematologic cancer	7.98e-05	0.000334	CcSEcCtD
Bezafibrate—Headache—Vinorelbine—hematologic cancer	7.93e-05	0.000333	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—hematologic cancer	7.92e-05	0.000332	CcSEcCtD
Bezafibrate—Hypersensitivity—Vincristine—hematologic cancer	7.9e-05	0.000331	CcSEcCtD
Bezafibrate—Pruritus—Alitretinoin—hematologic cancer	7.88e-05	0.00033	CcSEcCtD
Bezafibrate—Infection—Triamcinolone—hematologic cancer	7.83e-05	0.000328	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Epirubicin—hematologic cancer	7.82e-05	0.000328	CcSEcCtD
Bezafibrate—Pruritus—Ifosfamide—hematologic cancer	7.78e-05	0.000326	CcSEcCtD
Bezafibrate—Insomnia—Prednisolone—hematologic cancer	7.75e-05	0.000325	CcSEcCtD
Bezafibrate—Alopecia—Prednisone—hematologic cancer	7.75e-05	0.000325	CcSEcCtD
Bezafibrate—Dizziness—Thalidomide—hematologic cancer	7.74e-05	0.000324	CcSEcCtD
Bezafibrate—Nausea—Bortezomib—hematologic cancer	7.7e-05	0.000323	CcSEcCtD
Bezafibrate—Hypersensitivity—Irinotecan—hematologic cancer	7.7e-05	0.000323	CcSEcCtD
Bezafibrate—Hypersensitivity—Mitoxantrone—hematologic cancer	7.7e-05	0.000323	CcSEcCtD
Bezafibrate—Diarrhoea—Carmustine—hematologic cancer	7.69e-05	0.000322	CcSEcCtD
Bezafibrate—Nausea—Bleomycin—hematologic cancer	7.65e-05	0.00032	CcSEcCtD
Bezafibrate—Erythema—Prednisone—hematologic cancer	7.63e-05	0.00032	CcSEcCtD
Bezafibrate—Rash—Thiotepa—hematologic cancer	7.63e-05	0.00032	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—hematologic cancer	7.62e-05	0.000319	CcSEcCtD
Bezafibrate—Dermatitis—Thiotepa—hematologic cancer	7.62e-05	0.000319	CcSEcCtD
Bezafibrate—Diarrhoea—Alitretinoin—hematologic cancer	7.62e-05	0.000319	CcSEcCtD
Bezafibrate—Headache—Thiotepa—hematologic cancer	7.58e-05	0.000318	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	7.57e-05	0.000317	CcSEcCtD
Bezafibrate—Diarrhoea—Ifosfamide—hematologic cancer	7.53e-05	0.000315	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—hematologic cancer	7.53e-05	0.000315	CcSEcCtD
Bezafibrate—Nausea—Vinorelbine—hematologic cancer	7.52e-05	0.000315	CcSEcCtD
Bezafibrate—Myalgia—Dexamethasone—hematologic cancer	7.46e-05	0.000313	CcSEcCtD
Bezafibrate—Myalgia—Betamethasone—hematologic cancer	7.46e-05	0.000313	CcSEcCtD
Bezafibrate—Dizziness—Carmustine—hematologic cancer	7.43e-05	0.000311	CcSEcCtD
Bezafibrate—Constipation—Etoposide—hematologic cancer	7.43e-05	0.000311	CcSEcCtD
Bezafibrate—Pain—Etoposide—hematologic cancer	7.43e-05	0.000311	CcSEcCtD
Bezafibrate—Rash—Thalidomide—hematologic cancer	7.38e-05	0.000309	CcSEcCtD
Bezafibrate—Dermatitis—Thalidomide—hematologic cancer	7.37e-05	0.000309	CcSEcCtD
Bezafibrate—Dizziness—Alitretinoin—hematologic cancer	7.36e-05	0.000308	CcSEcCtD
Bezafibrate—Diarrhoea—Vincristine—hematologic cancer	7.34e-05	0.000308	CcSEcCtD
Bezafibrate—Headache—Thalidomide—hematologic cancer	7.33e-05	0.000307	CcSEcCtD
Bezafibrate—Pain—Prednisolone—hematologic cancer	7.33e-05	0.000307	CcSEcCtD
Bezafibrate—Dizziness—Ifosfamide—hematologic cancer	7.27e-05	0.000305	CcSEcCtD
Bezafibrate—Pharyngitis—Methotrexate—hematologic cancer	7.27e-05	0.000305	CcSEcCtD
Bezafibrate—Urinary tract disorder—Methotrexate—hematologic cancer	7.23e-05	0.000303	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—hematologic cancer	7.23e-05	0.000303	CcSEcCtD
Bezafibrate—Pruritus—Gemcitabine—hematologic cancer	7.2e-05	0.000302	CcSEcCtD
Bezafibrate—Nausea—Thiotepa—hematologic cancer	7.18e-05	0.000301	CcSEcCtD
Bezafibrate—Urethral disorder—Methotrexate—hematologic cancer	7.18e-05	0.000301	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	7.18e-05	0.000301	CcSEcCtD
Bezafibrate—Diarrhoea—Irinotecan—hematologic cancer	7.15e-05	0.0003	CcSEcCtD
Bezafibrate—Diarrhoea—Mitoxantrone—hematologic cancer	7.15e-05	0.0003	CcSEcCtD
Bezafibrate—Insomnia—Triamcinolone—hematologic cancer	7.13e-05	0.000299	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Etoposide—hematologic cancer	7.1e-05	0.000298	CcSEcCtD
Bezafibrate—Infection—Dexamethasone—hematologic cancer	7.1e-05	0.000298	CcSEcCtD
Bezafibrate—Infection—Betamethasone—hematologic cancer	7.1e-05	0.000298	CcSEcCtD
Bezafibrate—Dizziness—Vincristine—hematologic cancer	7.09e-05	0.000297	CcSEcCtD
Bezafibrate—Rash—Carmustine—hematologic cancer	7.08e-05	0.000297	CcSEcCtD
Bezafibrate—Dermatitis—Carmustine—hematologic cancer	7.08e-05	0.000297	CcSEcCtD
Bezafibrate—Anaemia—Prednisone—hematologic cancer	7.05e-05	0.000296	CcSEcCtD
Bezafibrate—Headache—Carmustine—hematologic cancer	7.04e-05	0.000295	CcSEcCtD
Bezafibrate—Rash—Alitretinoin—hematologic cancer	7.02e-05	0.000294	CcSEcCtD
Bezafibrate—Dermatitis—Alitretinoin—hematologic cancer	7.01e-05	0.000294	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	7.01e-05	0.000294	CcSEcCtD
Bezafibrate—Thrombocytopenia—Betamethasone—hematologic cancer	7e-05	0.000293	CcSEcCtD
Bezafibrate—Thrombocytopenia—Dexamethasone—hematologic cancer	7e-05	0.000293	CcSEcCtD
Bezafibrate—Hypersensitivity—Cisplatin—hematologic cancer	6.99e-05	0.000293	CcSEcCtD
Bezafibrate—Headache—Alitretinoin—hematologic cancer	6.97e-05	0.000292	CcSEcCtD
Bezafibrate—Diarrhoea—Gemcitabine—hematologic cancer	6.96e-05	0.000292	CcSEcCtD
Bezafibrate—Nausea—Thalidomide—hematologic cancer	6.95e-05	0.000291	CcSEcCtD
Bezafibrate—Dyspepsia—Triamcinolone—hematologic cancer	6.94e-05	0.000291	CcSEcCtD
Bezafibrate—Rash—Ifosfamide—hematologic cancer	6.94e-05	0.000291	CcSEcCtD
Bezafibrate—Dermatitis—Ifosfamide—hematologic cancer	6.93e-05	0.00029	CcSEcCtD
Bezafibrate—Erythema multiforme—Methotrexate—hematologic cancer	6.93e-05	0.00029	CcSEcCtD
Bezafibrate—Dizziness—Irinotecan—hematologic cancer	6.91e-05	0.000289	CcSEcCtD
Bezafibrate—Urticaria—Etoposide—hematologic cancer	6.9e-05	0.000289	CcSEcCtD
Bezafibrate—Abdominal pain—Etoposide—hematologic cancer	6.87e-05	0.000288	CcSEcCtD
Bezafibrate—Urticaria—Prednisolone—hematologic cancer	6.81e-05	0.000285	CcSEcCtD
Bezafibrate—Pharyngitis—Epirubicin—hematologic cancer	6.8e-05	0.000285	CcSEcCtD
Bezafibrate—Urinary tract disorder—Epirubicin—hematologic cancer	6.77e-05	0.000284	CcSEcCtD
Bezafibrate—Rash—Vincristine—hematologic cancer	6.76e-05	0.000283	CcSEcCtD
Bezafibrate—Dermatitis—Vincristine—hematologic cancer	6.76e-05	0.000283	CcSEcCtD
Bezafibrate—Pain—Triamcinolone—hematologic cancer	6.74e-05	0.000282	CcSEcCtD
Bezafibrate—Urethral disorder—Epirubicin—hematologic cancer	6.72e-05	0.000282	CcSEcCtD
Bezafibrate—Headache—Vincristine—hematologic cancer	6.72e-05	0.000282	CcSEcCtD
Bezafibrate—Nausea—Carmustine—hematologic cancer	6.67e-05	0.00028	CcSEcCtD
Bezafibrate—Nausea—Alitretinoin—hematologic cancer	6.61e-05	0.000277	CcSEcCtD
Bezafibrate—Rash—Mitoxantrone—hematologic cancer	6.59e-05	0.000276	CcSEcCtD
Bezafibrate—Rash—Irinotecan—hematologic cancer	6.59e-05	0.000276	CcSEcCtD
Bezafibrate—Dermatitis—Mitoxantrone—hematologic cancer	6.58e-05	0.000276	CcSEcCtD
Bezafibrate—Dermatitis—Irinotecan—hematologic cancer	6.58e-05	0.000276	CcSEcCtD
Bezafibrate—Headache—Irinotecan—hematologic cancer	6.54e-05	0.000274	CcSEcCtD
Bezafibrate—Headache—Mitoxantrone—hematologic cancer	6.54e-05	0.000274	CcSEcCtD
Bezafibrate—Nausea—Ifosfamide—hematologic cancer	6.53e-05	0.000274	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.51e-05	0.000273	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.51e-05	0.000273	CcSEcCtD
Bezafibrate—Myalgia—Prednisone—hematologic cancer	6.5e-05	0.000272	CcSEcCtD
Bezafibrate—Diarrhoea—Cisplatin—hematologic cancer	6.49e-05	0.000272	CcSEcCtD
Bezafibrate—Erythema multiforme—Epirubicin—hematologic cancer	6.48e-05	0.000272	CcSEcCtD
Bezafibrate—Alopecia—Methotrexate—hematologic cancer	6.47e-05	0.000271	CcSEcCtD
Bezafibrate—Insomnia—Betamethasone—hematologic cancer	6.47e-05	0.000271	CcSEcCtD
Bezafibrate—Insomnia—Dexamethasone—hematologic cancer	6.47e-05	0.000271	CcSEcCtD
Bezafibrate—Rash—Gemcitabine—hematologic cancer	6.42e-05	0.000269	CcSEcCtD
Bezafibrate—Dermatitis—Gemcitabine—hematologic cancer	6.41e-05	0.000269	CcSEcCtD
Bezafibrate—Hypersensitivity—Etoposide—hematologic cancer	6.4e-05	0.000268	CcSEcCtD
Bezafibrate—Erythema—Methotrexate—hematologic cancer	6.38e-05	0.000267	CcSEcCtD
Bezafibrate—Headache—Gemcitabine—hematologic cancer	6.37e-05	0.000267	CcSEcCtD
Bezafibrate—Nausea—Vincristine—hematologic cancer	6.37e-05	0.000267	CcSEcCtD
Bezafibrate—Hypersensitivity—Prednisolone—hematologic cancer	6.31e-05	0.000265	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—hematologic cancer	6.3e-05	0.000264	CcSEcCtD
Bezafibrate—Dyspepsia—Dexamethasone—hematologic cancer	6.29e-05	0.000264	CcSEcCtD
Bezafibrate—Dyspepsia—Betamethasone—hematologic cancer	6.29e-05	0.000264	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—hematologic cancer	6.26e-05	0.000263	CcSEcCtD
Bezafibrate—Urticaria—Triamcinolone—hematologic cancer	6.26e-05	0.000262	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—hematologic cancer	6.22e-05	0.000261	CcSEcCtD
Bezafibrate—Nausea—Irinotecan—hematologic cancer	6.2e-05	0.00026	CcSEcCtD
Bezafibrate—Nausea—Mitoxantrone—hematologic cancer	6.2e-05	0.00026	CcSEcCtD
Bezafibrate—Infection—Prednisone—hematologic cancer	6.19e-05	0.000259	CcSEcCtD
Bezafibrate—Pruritus—Etoposide—hematologic cancer	6.15e-05	0.000258	CcSEcCtD
Bezafibrate—Pain—Betamethasone—hematologic cancer	6.11e-05	0.000256	CcSEcCtD
Bezafibrate—Pain—Dexamethasone—hematologic cancer	6.11e-05	0.000256	CcSEcCtD
Bezafibrate—Alopecia—Epirubicin—hematologic cancer	6.06e-05	0.000254	CcSEcCtD
Bezafibrate—Nausea—Gemcitabine—hematologic cancer	6.04e-05	0.000253	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—hematologic cancer	6e-05	0.000251	CcSEcCtD
Bezafibrate—Rash—Cisplatin—hematologic cancer	5.98e-05	0.000251	CcSEcCtD
Bezafibrate—Dermatitis—Cisplatin—hematologic cancer	5.97e-05	0.00025	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—hematologic cancer	5.97e-05	0.00025	CcSEcCtD
Bezafibrate—Diarrhoea—Etoposide—hematologic cancer	5.94e-05	0.000249	CcSEcCtD
Bezafibrate—Anaemia—Methotrexate—hematologic cancer	5.89e-05	0.000247	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—hematologic cancer	5.88e-05	0.000246	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Betamethasone—hematologic cancer	5.85e-05	0.000245	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.85e-05	0.000245	CcSEcCtD
Bezafibrate—Hypersensitivity—Triamcinolone—hematologic cancer	5.81e-05	0.000243	CcSEcCtD
Bezafibrate—Dizziness—Etoposide—hematologic cancer	5.75e-05	0.000241	CcSEcCtD
Bezafibrate—Muscle spasms—Epirubicin—hematologic cancer	5.74e-05	0.00024	CcSEcCtD
Bezafibrate—Urticaria—Dexamethasone—hematologic cancer	5.68e-05	0.000238	CcSEcCtD
Bezafibrate—Urticaria—Betamethasone—hematologic cancer	5.68e-05	0.000238	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.67e-05	0.000238	CcSEcCtD
Bezafibrate—Dizziness—Prednisolone—hematologic cancer	5.67e-05	0.000237	CcSEcCtD
Bezafibrate—Abdominal pain—Dexamethasone—hematologic cancer	5.65e-05	0.000237	CcSEcCtD
Bezafibrate—Abdominal pain—Betamethasone—hematologic cancer	5.65e-05	0.000237	CcSEcCtD
Bezafibrate—Nausea—Cisplatin—hematologic cancer	5.63e-05	0.000236	CcSEcCtD
Bezafibrate—Insomnia—Prednisone—hematologic cancer	5.63e-05	0.000236	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—hematologic cancer	5.61e-05	0.000235	CcSEcCtD
Bezafibrate—Pruritus—Triamcinolone—hematologic cancer	5.58e-05	0.000234	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—hematologic cancer	5.52e-05	0.000231	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—hematologic cancer	5.52e-05	0.000231	CcSEcCtD
Bezafibrate—Dyspepsia—Prednisone—hematologic cancer	5.48e-05	0.00023	CcSEcCtD
Bezafibrate—Rash—Etoposide—hematologic cancer	5.48e-05	0.00023	CcSEcCtD
Bezafibrate—Dermatitis—Etoposide—hematologic cancer	5.47e-05	0.000229	CcSEcCtD
Bezafibrate—Headache—Etoposide—hematologic cancer	5.44e-05	0.000228	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—hematologic cancer	5.44e-05	0.000228	CcSEcCtD
Bezafibrate—Myalgia—Methotrexate—hematologic cancer	5.43e-05	0.000228	CcSEcCtD
Bezafibrate—Rash—Prednisolone—hematologic cancer	5.4e-05	0.000226	CcSEcCtD
Bezafibrate—Dermatitis—Prednisolone—hematologic cancer	5.4e-05	0.000226	CcSEcCtD
Bezafibrate—Headache—Prednisolone—hematologic cancer	5.37e-05	0.000225	CcSEcCtD
Bezafibrate—Constipation—Prednisone—hematologic cancer	5.33e-05	0.000223	CcSEcCtD
Bezafibrate—Muscle spasms—Doxorubicin—hematologic cancer	5.31e-05	0.000222	CcSEcCtD
Bezafibrate—Dizziness—Triamcinolone—hematologic cancer	5.21e-05	0.000218	CcSEcCtD
Bezafibrate—Infection—Methotrexate—hematologic cancer	5.17e-05	0.000217	CcSEcCtD
Bezafibrate—Nausea—Etoposide—hematologic cancer	5.16e-05	0.000216	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—hematologic cancer	5.1e-05	0.000214	CcSEcCtD
Bezafibrate—Thrombocytopenia—Methotrexate—hematologic cancer	5.1e-05	0.000214	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Prednisone—hematologic cancer	5.09e-05	0.000213	CcSEcCtD
Bezafibrate—Nausea—Prednisolone—hematologic cancer	5.09e-05	0.000213	CcSEcCtD
Bezafibrate—Myalgia—Epirubicin—hematologic cancer	5.08e-05	0.000213	CcSEcCtD
Bezafibrate—Pruritus—Dexamethasone—hematologic cancer	5.06e-05	0.000212	CcSEcCtD
Bezafibrate—Pruritus—Betamethasone—hematologic cancer	5.06e-05	0.000212	CcSEcCtD
Bezafibrate—Rash—Triamcinolone—hematologic cancer	4.97e-05	0.000208	CcSEcCtD
Bezafibrate—Dermatitis—Triamcinolone—hematologic cancer	4.96e-05	0.000208	CcSEcCtD
Bezafibrate—Urticaria—Prednisone—hematologic cancer	4.95e-05	0.000207	CcSEcCtD
Bezafibrate—Headache—Triamcinolone—hematologic cancer	4.94e-05	0.000207	CcSEcCtD
Bezafibrate—Abdominal pain—Prednisone—hematologic cancer	4.92e-05	0.000206	CcSEcCtD
Bezafibrate—Diarrhoea—Betamethasone—hematologic cancer	4.89e-05	0.000205	CcSEcCtD
Bezafibrate—Diarrhoea—Dexamethasone—hematologic cancer	4.89e-05	0.000205	CcSEcCtD
Bezafibrate—Infection—Epirubicin—hematologic cancer	4.84e-05	0.000203	CcSEcCtD
Bezafibrate—Thrombocytopenia—Epirubicin—hematologic cancer	4.77e-05	0.0002	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.74e-05	0.000199	CcSEcCtD
Bezafibrate—Dizziness—Betamethasone—hematologic cancer	4.73e-05	0.000198	CcSEcCtD
Bezafibrate—Dizziness—Dexamethasone—hematologic cancer	4.73e-05	0.000198	CcSEcCtD
Bezafibrate—Insomnia—Methotrexate—hematologic cancer	4.71e-05	0.000197	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—hematologic cancer	4.7e-05	0.000197	CcSEcCtD
Bezafibrate—Nausea—Triamcinolone—hematologic cancer	4.68e-05	0.000196	CcSEcCtD
Bezafibrate—Hypersensitivity—Prednisone—hematologic cancer	4.59e-05	0.000192	CcSEcCtD
Bezafibrate—Dyspepsia—Methotrexate—hematologic cancer	4.58e-05	0.000192	CcSEcCtD
Bezafibrate—Rash—Betamethasone—hematologic cancer	4.51e-05	0.000189	CcSEcCtD
Bezafibrate—Rash—Dexamethasone—hematologic cancer	4.51e-05	0.000189	CcSEcCtD
Bezafibrate—Dermatitis—Betamethasone—hematologic cancer	4.5e-05	0.000189	CcSEcCtD
Bezafibrate—Dermatitis—Dexamethasone—hematologic cancer	4.5e-05	0.000189	CcSEcCtD
Bezafibrate—Headache—Dexamethasone—hematologic cancer	4.48e-05	0.000188	CcSEcCtD
Bezafibrate—Headache—Betamethasone—hematologic cancer	4.48e-05	0.000188	CcSEcCtD
Bezafibrate—Infection—Doxorubicin—hematologic cancer	4.48e-05	0.000188	CcSEcCtD
Bezafibrate—Pain—Methotrexate—hematologic cancer	4.45e-05	0.000187	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.44e-05	0.000186	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—hematologic cancer	4.41e-05	0.000185	CcSEcCtD
Bezafibrate—Pruritus—Prednisone—hematologic cancer	4.41e-05	0.000185	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—hematologic cancer	4.41e-05	0.000185	CcSEcCtD
Bezafibrate—Dyspepsia—Epirubicin—hematologic cancer	4.29e-05	0.00018	CcSEcCtD
Bezafibrate—Diarrhoea—Prednisone—hematologic cancer	4.26e-05	0.000179	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Methotrexate—hematologic cancer	4.26e-05	0.000178	CcSEcCtD
Bezafibrate—Nausea—Dexamethasone—hematologic cancer	4.25e-05	0.000178	CcSEcCtD
Bezafibrate—Nausea—Betamethasone—hematologic cancer	4.25e-05	0.000178	CcSEcCtD
Bezafibrate—Constipation—Epirubicin—hematologic cancer	4.16e-05	0.000175	CcSEcCtD
Bezafibrate—Pain—Epirubicin—hematologic cancer	4.16e-05	0.000175	CcSEcCtD
Bezafibrate—Urticaria—Methotrexate—hematologic cancer	4.13e-05	0.000173	CcSEcCtD
Bezafibrate—Dizziness—Prednisone—hematologic cancer	4.12e-05	0.000173	CcSEcCtD
Bezafibrate—Abdominal pain—Methotrexate—hematologic cancer	4.11e-05	0.000172	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.11e-05	0.000172	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—hematologic cancer	4.08e-05	0.000171	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Epirubicin—hematologic cancer	3.98e-05	0.000167	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—hematologic cancer	3.97e-05	0.000166	CcSEcCtD
Bezafibrate—Rash—Prednisone—hematologic cancer	3.93e-05	0.000165	CcSEcCtD
Bezafibrate—Dermatitis—Prednisone—hematologic cancer	3.92e-05	0.000164	CcSEcCtD
Bezafibrate—Headache—Prednisone—hematologic cancer	3.9e-05	0.000163	CcSEcCtD
Bezafibrate—Urticaria—Epirubicin—hematologic cancer	3.87e-05	0.000162	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—hematologic cancer	3.85e-05	0.000162	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—hematologic cancer	3.85e-05	0.000162	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—hematologic cancer	3.85e-05	0.000161	CcSEcCtD
Bezafibrate—Hypersensitivity—Methotrexate—hematologic cancer	3.83e-05	0.000161	CcSEcCtD
Bezafibrate—Nausea—Prednisone—hematologic cancer	3.7e-05	0.000155	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.69e-05	0.000154	CcSEcCtD
Bezafibrate—Pruritus—Methotrexate—hematologic cancer	3.68e-05	0.000154	CcSEcCtD
Bezafibrate—Hypersensitivity—Epirubicin—hematologic cancer	3.59e-05	0.00015	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—hematologic cancer	3.58e-05	0.00015	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—hematologic cancer	3.56e-05	0.000149	CcSEcCtD
Bezafibrate—Diarrhoea—Methotrexate—hematologic cancer	3.56e-05	0.000149	CcSEcCtD
Bezafibrate—Pruritus—Epirubicin—hematologic cancer	3.45e-05	0.000144	CcSEcCtD
Bezafibrate—Dizziness—Methotrexate—hematologic cancer	3.44e-05	0.000144	CcSEcCtD
Bezafibrate—Diarrhoea—Epirubicin—hematologic cancer	3.33e-05	0.00014	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—hematologic cancer	3.32e-05	0.000139	CcSEcCtD
Bezafibrate—Rash—Methotrexate—hematologic cancer	3.28e-05	0.000138	CcSEcCtD
Bezafibrate—Dermatitis—Methotrexate—hematologic cancer	3.28e-05	0.000137	CcSEcCtD
Bezafibrate—Headache—Methotrexate—hematologic cancer	3.26e-05	0.000137	CcSEcCtD
Bezafibrate—Dizziness—Epirubicin—hematologic cancer	3.22e-05	0.000135	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—hematologic cancer	3.19e-05	0.000134	CcSEcCtD
Bezafibrate—Nausea—Methotrexate—hematologic cancer	3.09e-05	0.00013	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—hematologic cancer	3.08e-05	0.000129	CcSEcCtD
Bezafibrate—Rash—Epirubicin—hematologic cancer	3.07e-05	0.000129	CcSEcCtD
Bezafibrate—Dermatitis—Epirubicin—hematologic cancer	3.07e-05	0.000129	CcSEcCtD
Bezafibrate—Headache—Epirubicin—hematologic cancer	3.05e-05	0.000128	CcSEcCtD
Bezafibrate—Dizziness—Doxorubicin—hematologic cancer	2.98e-05	0.000125	CcSEcCtD
Bezafibrate—Nausea—Epirubicin—hematologic cancer	2.89e-05	0.000121	CcSEcCtD
Bezafibrate—Rash—Doxorubicin—hematologic cancer	2.84e-05	0.000119	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—hematologic cancer	2.84e-05	0.000119	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—hematologic cancer	2.82e-05	0.000118	CcSEcCtD
Bezafibrate—Nausea—Doxorubicin—hematologic cancer	2.68e-05	0.000112	CcSEcCtD
Bezafibrate—CYP1A1—Metabolism—ARNTL—hematologic cancer	1.05e-05	6.66e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.05e-05	6.66e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NRAS—hematologic cancer	1.05e-05	6.65e-05	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—hematologic cancer	1.04e-05	6.58e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.04e-05	6.57e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTP1—hematologic cancer	1.04e-05	6.56e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.04e-05	6.55e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.03e-05	6.53e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.03e-05	6.53e-05	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—hematologic cancer	1.03e-05	6.5e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMMR—hematologic cancer	1.03e-05	6.5e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—IDH2—hematologic cancer	1.03e-05	6.5e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CA9—hematologic cancer	1.02e-05	6.48e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ACP5—hematologic cancer	1.02e-05	6.48e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NCOR2—hematologic cancer	1.01e-05	6.4e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK3—hematologic cancer	1.01e-05	6.37e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1e-05	6.35e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CREBBP—hematologic cancer	1e-05	6.33e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CB—hematologic cancer	9.93e-06	6.28e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CG—hematologic cancer	9.87e-06	6.25e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCB1—hematologic cancer	9.81e-06	6.21e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK14—hematologic cancer	9.81e-06	6.21e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NQO1—hematologic cancer	9.79e-06	6.19e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CD44—hematologic cancer	9.79e-06	6.19e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TGFB1—hematologic cancer	9.76e-06	6.18e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.68e-06	6.13e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ARNTL—hematologic cancer	9.65e-06	6.11e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—IDH1—hematologic cancer	9.63e-06	6.09e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR1—hematologic cancer	9.62e-06	6.09e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.58e-06	6.07e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTM1—hematologic cancer	9.53e-06	6.03e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—NCOR1—hematologic cancer	9.53e-06	6.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTO1—hematologic cancer	9.52e-06	6.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCC3—hematologic cancer	9.52e-06	6.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TXN—hematologic cancer	9.52e-06	6.03e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CD—hematologic cancer	9.49e-06	6e-05	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—hematologic cancer	9.47e-06	5.99e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MAPK3—hematologic cancer	9.42e-06	5.97e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ACP5—hematologic cancer	9.39e-06	5.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CA9—hematologic cancer	9.39e-06	5.94e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—hematologic cancer	9.36e-06	5.93e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SPHK1—hematologic cancer	9.32e-06	5.9e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH1—hematologic cancer	9.3e-06	5.89e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NCOR2—hematologic cancer	9.26e-06	5.86e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYCS—hematologic cancer	9.26e-06	5.86e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HSP90AA1—hematologic cancer	9.2e-06	5.82e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—hematologic cancer	9.17e-06	5.8e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CREBBP—hematologic cancer	9.15e-06	5.79e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—hematologic cancer	9.11e-06	5.77e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—hematologic cancer	9.04e-06	5.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ASNS—hematologic cancer	9.02e-06	5.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—DCK—hematologic cancer	9.02e-06	5.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.02e-06	5.71e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3R1—hematologic cancer	8.96e-06	5.67e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—UGT1A1—hematologic cancer	8.95e-06	5.67e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—IDH1—hematologic cancer	8.83e-06	5.59e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCC3—hematologic cancer	8.73e-06	5.52e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTO1—hematologic cancer	8.73e-06	5.52e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TXN—hematologic cancer	8.73e-06	5.52e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CRABP1—hematologic cancer	8.71e-06	5.51e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC22A1—hematologic cancer	8.71e-06	5.51e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CD—hematologic cancer	8.68e-06	5.49e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTEN—hematologic cancer	8.58e-06	5.43e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—hematologic cancer	8.56e-06	5.42e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HDC—hematologic cancer	8.55e-06	5.41e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SPHK1—hematologic cancer	8.54e-06	5.41e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALOX5—hematologic cancer	8.48e-06	5.37e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—CREBBP—hematologic cancer	8.43e-06	5.34e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—hematologic cancer	8.42e-06	5.33e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.28e-06	5.24e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CB—hematologic cancer	8.27e-06	5.23e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NUP98—hematologic cancer	8.22e-06	5.2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—UGT1A1—hematologic cancer	8.2e-06	5.19e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3R1—hematologic cancer	8.19e-06	5.19e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—EP300—hematologic cancer	8.18e-06	5.18e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—hematologic cancer	8.16e-06	5.17e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC22A1—hematologic cancer	7.98e-06	5.05e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CRABP1—hematologic cancer	7.98e-06	5.05e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ADCY7—hematologic cancer	7.98e-06	5.05e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NCOA3—hematologic cancer	7.98e-06	5.05e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NUP214—hematologic cancer	7.92e-06	5.01e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.9e-06	5e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.84e-06	4.96e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CDA—hematologic cancer	7.82e-06	4.95e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALOX5—hematologic cancer	7.78e-06	4.92e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCG2—hematologic cancer	7.76e-06	4.91e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTR—hematologic cancer	7.76e-06	4.91e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCB1—hematologic cancer	7.73e-06	4.89e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—hematologic cancer	7.69e-06	4.86e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ENO2—hematologic cancer	7.61e-06	4.82e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CB—hematologic cancer	7.56e-06	4.79e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NUP98—hematologic cancer	7.53e-06	4.77e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PC—hematologic cancer	7.53e-06	4.76e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NCOR1—hematologic cancer	7.5e-06	4.75e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—hematologic cancer	7.5e-06	4.75e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.42e-06	4.7e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTT1—hematologic cancer	7.38e-06	4.67e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—hematologic cancer	7.36e-06	4.66e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ADCY7—hematologic cancer	7.31e-06	4.63e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NCOA3—hematologic cancer	7.31e-06	4.63e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.27e-06	4.6e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GBA—hematologic cancer	7.27e-06	4.6e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.27e-06	4.6e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NUP214—hematologic cancer	7.26e-06	4.6e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SDC1—hematologic cancer	7.21e-06	4.57e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.19e-06	4.55e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MAPK3—hematologic cancer	7.18e-06	4.55e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTEN—hematologic cancer	7.14e-06	4.52e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCG2—hematologic cancer	7.11e-06	4.5e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTR—hematologic cancer	7.11e-06	4.5e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CG—hematologic cancer	7.07e-06	4.48e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—hematologic cancer	6.98e-06	4.42e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ENO2—hematologic cancer	6.98e-06	4.42e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.89e-06	4.36e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—EP300—hematologic cancer	6.81e-06	4.31e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.8e-06	4.31e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—hematologic cancer	6.79e-06	4.3e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTT1—hematologic cancer	6.77e-06	4.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.66e-06	4.22e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTAP—hematologic cancer	6.65e-06	4.21e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—hematologic cancer	6.63e-06	4.2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SDC1—hematologic cancer	6.61e-06	4.19e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CREBBP—hematologic cancer	6.56e-06	4.15e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTEN—hematologic cancer	6.53e-06	4.14e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.51e-06	4.12e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—hematologic cancer	6.36e-06	4.02e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.32e-06	4e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.24e-06	3.95e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—EP300—hematologic cancer	6.23e-06	3.94e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CD—hematologic cancer	6.22e-06	3.94e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—hematologic cancer	6.14e-06	3.89e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NQO1—hematologic cancer	6.13e-06	3.88e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CD44—hematologic cancer	6.13e-06	3.88e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—hematologic cancer	6.05e-06	3.83e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.01e-06	3.8e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.97e-06	3.78e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FHL2—hematologic cancer	5.93e-06	3.75e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3R1—hematologic cancer	5.87e-06	3.72e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.84e-06	3.7e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AGRN—hematologic cancer	5.81e-06	3.68e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYCS—hematologic cancer	5.8e-06	3.67e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	5.77e-06	3.65e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NQO1—hematologic cancer	5.62e-06	3.56e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CD44—hematologic cancer	5.62e-06	3.56e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	5.57e-06	3.53e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMMR—hematologic cancer	5.51e-06	3.49e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—IDH2—hematologic cancer	5.51e-06	3.49e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.51e-06	3.49e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CB—hematologic cancer	5.42e-06	3.43e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYCS—hematologic cancer	5.32e-06	3.37e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.29e-06	3.35e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.19e-06	3.29e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.18e-06	3.28e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CREBBP—hematologic cancer	5.16e-06	3.27e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK3—hematologic cancer	5.15e-06	3.26e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—hematologic cancer	5.12e-06	3.24e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—hematologic cancer	5.04e-06	3.19e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ACP5—hematologic cancer	5.04e-06	3.19e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA9—hematologic cancer	5.04e-06	3.19e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—hematologic cancer	5.01e-06	3.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.97e-06	3.15e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.95e-06	3.13e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—hematologic cancer	4.94e-06	3.13e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	4.9e-06	3.1e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—hematologic cancer	4.84e-06	3.07e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCB1—hematologic cancer	4.84e-06	3.07e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—hematologic cancer	4.83e-06	3.06e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.76e-06	3.01e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—IDH1—hematologic cancer	4.74e-06	3e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NCOR1—hematologic cancer	4.7e-06	2.98e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—hematologic cancer	4.7e-06	2.98e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.69e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TXN—hematologic cancer	4.68e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.68e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.68e-06	2.97e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTEN—hematologic cancer	4.68e-06	2.96e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	4.62e-06	2.93e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—hematologic cancer	4.61e-06	2.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.58e-06	2.9e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.54e-06	2.87e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—EP300—hematologic cancer	4.47e-06	2.83e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.44e-06	2.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.4e-06	2.79e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.31e-06	2.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.31e-06	2.73e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.28e-06	2.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.28e-06	2.71e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	4.27e-06	2.7e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.17e-06	2.64e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—hematologic cancer	4.15e-06	2.63e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—hematologic cancer	4.12e-06	2.61e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NUP98—hematologic cancer	4.04e-06	2.56e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.93e-06	2.48e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.93e-06	2.48e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NUP214—hematologic cancer	3.9e-06	2.47e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.82e-06	2.42e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTR—hematologic cancer	3.82e-06	2.42e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.81e-06	2.41e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—hematologic cancer	3.77e-06	2.38e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENO2—hematologic cancer	3.74e-06	2.37e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTEN—hematologic cancer	3.69e-06	2.33e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.66e-06	2.32e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.63e-06	2.3e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SDC1—hematologic cancer	3.55e-06	2.25e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—EP300—hematologic cancer	3.52e-06	2.23e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CG—hematologic cancer	3.49e-06	2.21e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—hematologic cancer	3.47e-06	2.2e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.36e-06	2.12e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—hematologic cancer	3.3e-06	2.09e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CREBBP—hematologic cancer	3.24e-06	2.05e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.2e-06	2.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CD—hematologic cancer	3.07e-06	1.94e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—hematologic cancer	3.03e-06	1.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NQO1—hematologic cancer	3.02e-06	1.91e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CD44—hematologic cancer	3.02e-06	1.91e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.97e-06	1.88e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.9e-06	1.83e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYCS—hematologic cancer	2.86e-06	1.81e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.84e-06	1.8e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.81e-06	1.78e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—hematologic cancer	2.78e-06	1.76e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—hematologic cancer	2.7e-06	1.71e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CB—hematologic cancer	2.67e-06	1.69e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.66e-06	1.68e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2.6e-06	1.65e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.52e-06	1.59e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.45e-06	1.55e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.38e-06	1.51e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.31e-06	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.31e-06	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTEN—hematologic cancer	2.31e-06	1.46e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—EP300—hematologic cancer	2.2e-06	1.4e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—hematologic cancer	2.13e-06	1.35e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTEN—hematologic cancer	2.12e-06	1.34e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.04e-06	1.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—EP300—hematologic cancer	2.02e-06	1.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.72e-06	1.09e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.63e-06	1.03e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.59e-06	1.01e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.51e-06	9.56e-06	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.49e-06	9.46e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—hematologic cancer	1.49e-06	9.44e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.43e-06	9.03e-06	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—hematologic cancer	1.33e-06	8.43e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.32e-06	8.33e-06	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—hematologic cancer	1.22e-06	7.73e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTEN—hematologic cancer	1.14e-06	7.2e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—EP300—hematologic cancer	1.08e-06	6.87e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.02e-07	5.08e-06	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—hematologic cancer	6.55e-07	4.15e-06	CbGpPWpGaD
